Version 1
: Received: 4 September 2024 / Approved: 5 September 2024 / Online: 5 September 2024 (08:20:35 CEST)
How to cite:
Long, C.-Y.; Chang, C.-Y.; Sung, I.-C.; Loo, Z.-X.; Lin, K.-L. The Therapeutic Effect of Monopolar Radiofrequency Therapy on Urinary Symptoms and Sexual Function. Preprints2024, 2024090419. https://doi.org/10.20944/preprints202409.0419.v1
Long, C.-Y.; Chang, C.-Y.; Sung, I.-C.; Loo, Z.-X.; Lin, K.-L. The Therapeutic Effect of Monopolar Radiofrequency Therapy on Urinary Symptoms and Sexual Function. Preprints 2024, 2024090419. https://doi.org/10.20944/preprints202409.0419.v1
Long, C.-Y.; Chang, C.-Y.; Sung, I.-C.; Loo, Z.-X.; Lin, K.-L. The Therapeutic Effect of Monopolar Radiofrequency Therapy on Urinary Symptoms and Sexual Function. Preprints2024, 2024090419. https://doi.org/10.20944/preprints202409.0419.v1
APA Style
Long, C. Y., Chang, C. Y., Sung, I. C., Loo, Z. X., & Lin, K. L. (2024). The Therapeutic Effect of Monopolar Radiofrequency Therapy on Urinary Symptoms and Sexual Function. Preprints. https://doi.org/10.20944/preprints202409.0419.v1
Chicago/Turabian Style
Long, C., Zi-Xi Loo and Kun-Ling Lin. 2024 "The Therapeutic Effect of Monopolar Radiofrequency Therapy on Urinary Symptoms and Sexual Function" Preprints. https://doi.org/10.20944/preprints202409.0419.v1
Abstract
Objectives: Stress urinary incontinence (SUI) negatively affects the quality of life and sexual function in women. This study aimed to evaluate the efficacy of radiofrequency (RF) therapy in reducing SUI symptoms and its impact on sexual function. Methods: Thirty-four women with SUI were enrolled and underwent a single RF treatment session using the Viveve® System (Viveve Medical Inc., USA) with parameters of 90 J/cm² and 220 pulses per hour. Assessments at baseline and 6 months post-treatment included perineal ultrasound and personal interviews to evaluate lower urinary tract symptoms and sexual function. Urodynamic studies, voiding diaries, and questionnaires such as the Female Sexual Function Index (FSFI), Overactive Bladder Symp-tom Score (OABSS), Urogenital Distress Inventory-6 (UDI-6), Incontinence Impact Question-naire-7 (IIQ-7), and International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) measured outcomes. Results: RF therapy significantly improved sexual function, with higher FSFI scores in all domains except pain at 6 months. SUI symptoms were significantly re-duced, as indicated by improved scores on OABSS, UDI-6, IIQ-7, and ICIQ-SF, alongside better voiding diary results. Anatomical changes included reduced bladder neck mobility, decreased vaginal width, and a reduced rotation angle of the proximal urethra. Conclusions: RF therapy is effective and safe for treating mild to moderate SUI and enhances sexual function, potentially due to changes in vaginal topography. These results suggest RF therapy as a viable non-surgical op-tion for managing SUI and improving sexual health.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
